Stentys amps up Q1 sales; Intuitive pays Luna a $6M milestone;

@FierceMedDev: Stryker's sales jump after string of M&A deals. More | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Zimmer buying fellow orthopedics company Biomet for $13.35 billion. | Follow @VarunSaxena2

@EmilyWFierce: Security holes in a number of commonly used medical devices could leave them open to attack. Article | Follow @EmilyWFierce

@MichaelGFierce: ICYMI: DNA nanocages that act like viruses bypass the immune system to deliver drugs. Story | Follow @MichaelGFierce

> French devicemaker Stentys boosted its revenue by 18% in the first quarter, thanks largely to a spike in demand for its self-apposing cardiac stent. Results

> Intuitive Surgical ($ISRG) has handed out another $6 million milestone to Luna Innovations, part of a deal that could pay the company as much as $30 million. More

Biotech News

@FierceBiotech: EuroBiotech Report: GlaxoSmithKline & Novartis reshape EU biotech, Celgene, Hyperion in Euro deals, U.K. cell therapy grows, and more. Report | Follow @FierceBiotech

@JohnCFierce: Pyott told me back in January he could easily spend $10 billion on buyouts. Though that's not Shire territory. Story from January | Follow @JohnCFierce

@DamianFierce: ICYMI: Celgene opens down 5%. Perhaps a $710M deal didn't thrill investors who just watched R&D costs drag profits. | Follow @DamianFierce

@EmilyMFierce: Blood of world's oldest woman hints at limits of life. More | Follow @EmilyMFierce

> Arch Venture swings for a $250M fund to bet on biotechs. Story

> Buyout buzz: Allergan made a pass at Shire before Valeant came calling. Article

> Radius dials up a $92M IPO pitch despite tepid market for biotechs. News

Pharma News

@FiercePharma: Top-read on FiercePharmaManufacturing Thurs: Hospira recalls 7 lots of propofol and one of lidocaine Story | Follow @FiercePharma

@TracyStaton: @Indianmarketeer: Novartis seems to think it can pump up sales of GSK's drugs better than GSK could. But as you say, time will tell. | Follow @TracyStaton

@EricPFierce: A large block of #AstraZeneca shareholders voted against the company's pay plan and one of its directors. More | Follow @EricPFierce

@CarlyHFierce: Arena - Television Ads Raise Awareness. Report from SeekingAlpha | Follow @CarlyHFierce

> Pfizer, Novartis and 3 others put an extra $1M each into Q1 lobbying. Story

> AbbVie's Humira turns in 18% surge in sales. More

> Reuters: Allergan broached deal with Shire before Valeant's hostile bid. Article

Suggested Articles

The FDA has cleared its first fully disposable duodenoscope, following years of reports of infections being transmitted between patients.

OR-focused AI provider Caresyntax has garnered $45.6 million in new funding and picked up a data analytics firm to broaden its footprint.

A study of Foundation Medicine’s FoundationOne liquid biopsy test found it was able to predict the risk that a person’s breast cancer would return.